Stephen Richardson at [NYU Langone Medical Center]

Stephen B. Richardson, MD

  • Specialty: Endocrinology
  • Language: English
  • Phone: 212-481-1350

About Me

Conditions and Treatments

galactorrhea, neuroendocrine tumor, pituitary disorders, multiple endocrine neoplasia, calcium disorders, insulin dependent diabetes, hypothyroidism, subacute thyroiditis, cushing's syndrome, diabetes mellitus complications, hypogonadotropic hypogonadism, hyperparathyroidism, pregnancy induced diabetes, chronic thyroiditis, hypoparathyroidism, hypopituitarism, thyroid diseases, silent thyroiditis, postpartum thyroiditis, pituitary adenoma, metabolic bone disease, metabolic syndrome, prediabetes, osteoporosis, autoimmune thyroid disease, parathyroid disease, pituitary tumor, nutritional therapy, prolactinoma, acromegaly, diabetes, hyperthyroidism, type 2 diabetes mellitus, diabetes insipidus, graves' disease, craniopharyngioma, thyroiditis
Show More Conditions

Credentials

Positions
  • Associate Professor, Department of Medicine
Board Certifications
  • American Board of Internal Medicine (Endocrinology, Diabetes & Metabolism), 1983
  • American Board of Internal Medicine - Internal Medicine, 1981
Education and Training
  • Fellowship, NYU Medical Center, Endocrinology, 1978
  • MD from Kings College, 1971
Departments

Locations and Appointments

57 Insurance Plans Accepted
  • Aetna HMO
  • Aetna Indemnity
  • Aetna Medicare
  • Aetna POS
  • Aetna PPO/EPO
  • Affinity
  • Affinity Exchange- Essential
  • Alphacare
  • Cigna EPO/POS
  • Cigna PPO
  • ElderPlan
  • Empire Blue Cross Blue Shield EPO
  • Empire Blue Cross Blue Shield HMO
  • Empire Blue Cross Blue Shield HealthPlus
  • Empire Blue Cross Blue Shield HealthPlus Essential
  • Empire Blue Cross Blue Shield Indemnity
  • Empire Blue Cross Blue Shield MediBlue
  • Empire Blue Cross Blue Shield POS
  • Empire Blue Cross Blue Shield PPO
  • Empire Blue Cross Blue Shield Pathways, Enhanced
  • Fidelis Child Health
  • Fidelis Exchange
  • Fidelis Family Health
  • Fidelis Medicare
  • HIP Access I
  • HIP Access II
  • HIP Child Health
  • HIP EPO/PPO
  • HIP HMO
  • HIP Medicare
  • HIP POS
  • Healthfirst
  • Healthfirst Essential
  • Humana Medicare
  • MagnaCare PPO
  • Medicare
  • MetroPlus Child Health
  • MetroPlus Essential
  • MetroPlus Exchange Plans
  • MetroPlus Family Health
  • MetroPlus Medicaid
  • MetroPlus Medicare
  • MultiPlan/PHCS PPO
  • NY Medicaid
  • Oscar
  • Oxford Freedom
  • Oxford Medicare
  • Tricare
  • UPN Elite
  • UnitedHealthcare EPO
  • UnitedHealthcare HMO
  • UnitedHealthcare Medicare
  • UnitedHealthcare POS
  • UnitedHealthcare PPO
  • UnitedHealthcare Top Tier
  • Visiting Nurse Service (VNS) Medicare
  • WellCare Child Health
*Insurance listed above may not be accepted at all office locations. Please confirm prior to each visit. The information presented here may not be complete or may have been changed.
NYU Diabetes & Endocrine Associates

530 1st Avenue, Suite 5E
New York, NY 10016

Contact

Phone: 212-481-1350

Welcome back!

As a returning patient for this doctor, please schedule an appointment using your MyChart at NYU Langone account.

Learn more about MyChart at NYU Langone.

My Research

We investigate the regulation of insulin secretion i. in the physiological state ii. in noninsulin-dependent diabetes in which insulin secretion is defective and pancreatic beta cells fail to respond to glucose. We found that the pancreas contains immunoreactive vasopressin (VP)-like material, that VP is a powerful and unique insulin secretagogue able to stimulate secretion in the absence of glucose while potentiating glucose-induced insulin secretion, and that beta cells express VP receptors which strongly resemble corticotrophic V1b receptors. We are characterizing the beta cell V1 receptor by PCR to determine whether it belongs to the V1b-type or represents a novel subclass of VP receptor.

We also study the role of the GH-IGF1 axis in the development of diabetic retinopathy. Using endothelial cell lines and umbilical vein endothelial cells, we research the signal transduction pathways stimulated by angiogenic growth factors and their interactions with known or putative inhibitors of angiogenesis and endothelial proliferation such as somatostatin and its analogs.

Publications

  • Modifiers of cognitive function and brain structure in middle-aged and elderly individuals with type 2 diabetes mellitus

    Bruehl, Hannah; Wolf, Oliver T; Sweat, Victoria; Tirsi, Aziz; Richardson, Stephen; Convit, Antonio
    Brain research. 2009 May 20. 1280: 186-194

  • Hippocampal damage and memory impairments as possible early brain complications of type 2 diabetes

    Gold, S M; Dziobek, I; Sweat, V; Tirsi, A; Rogers, K; Bruehl, H; Tsui, W; Richardson, S; Javier, E; Convit, A
    Diabetologia. 2007 Feb 14. 50 (4): 711-719

  • The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus

    Albrecht, Joerg; Taylor, Lynne; Berlin, Jesse A; Dulay, Samuel; Ang, Gina; Fakharzadeh, Steven; Kantor, Jonathan; Kim, Ellen; Militello, Giuseppe; McGinnis, Karen; Richardson, Stephen; Treat, James; Vittorio, Carmela; Van Voorhees, Abby; Werth, Victoria P
    Journal of investigative dermatology. 2005 Nov . 125 (5): 889-894

Read All Publications (44)